Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Functional Outcomes for Stereotactic Body Radiotherapy of Lung Lesions in High Risk Patients

NCT03121300 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT03121300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03121300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Functional Outcomes for Stereotactic Body Radiotherapy of Lung Lesions in High Risk Patients
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Observational
Overall status
Completed
Start date
February 6, 2017
Completion date
August 30, 2019
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer